Abstract:Aims: Altered mechanical load in response to injury is a main driver of myocardial interstitial fibrosis. No current in vitro model can precisely modulate mechanical load in a multicellular environment while maintaining physiological behaviour. Living myocardial slices (LMS) are a 300 μm-thick cardiac preparation with preserved physiological structure and function. Here we apply varying degrees of mechanical preload to rat and human LMS to evaluate early cellular, molecular, and functionality changes related to myocardial fibrosis. Methods and results: Left ventricular LMS were obtained from Sprague Dawley rat hearts and human cardiac samples from healthy and failing (dilated cardiomyopathy) hearts. LMS were mounted on custom stretchers and two degrees of diastolic load were applied: physiological sarcomere length (SL) (SL = 2.2 μm) and overload (SL = 2.4 μm). LMS were maintained for 48 h under electrical stimulation in circulating, oxygenated media at 37°C. In overloaded conditions, LMS displayed an increase in nucleus translocation of Yes-associated protein (YAP) and an up-regulation of mechanotransduction markers without loss in cell viability. Expression of fibrotic and inflammatory markers, as well as Collagen I deposition were also observed. Functionally, overloaded LMS displayed lower contractility (7.48 ± 3.07 mN mm-2 at 2.2 SL vs. 3.53 ± 1.80 mN mm-2 at 2.4 SL). The addition of the profibrotic protein interleukin-11 (IL-11) showed similar results to the application of overload with enhanced fibrosis (8% more of collagen surface coverage) and reduced LMS contractility at physiological load. Conversely, treatment with the Transforming growth factor β receptor (TGF-βR) blocker SB-431542, showed down-regulation of genes associated with mechanical stress, prevention of fibrotic response and improvement in cardiac function despite overload (from 2.40 ± 0.8 mN mm-2 to 4.60 ± 1.08 mN mm-2 ). Conclusions: The LMS have a consistent fibrotic remodelling response to pathological load, which can be modulated by a TGF-βR blocker. The LMS platform allows the study of mechanosensitive molecular mechanisms of myocardial fibrosis and can lead to the development of novel therapeutic strategies.

Cardiac fibroblasts and mechanosensation in heart development, health and disease

Mechanoregulation of Cardiac Myofibroblast Differentiation: Implications for Cardiac Fibrosis and Therapy

Mechanotransduction in the Cardiovascular System: From Developmental Origins to Homeostasis and Pathology

Mechanical control of cardiac myofibroblasts

The local mechanosensitive response of primary cardiac fibroblasts is influenced by the microenvironment mechanics

Cardiac Fibrotic Remodeling on a Chip with Dynamic Mechanical Stimulation.

Mechanical Communication in Fibrosis Progression

Full title: Mechano-regulation of Cardiac Myofibroblast Differentiation: Implications

Focal Adhesion's Role in Cardiomyocytes Function: From Cardiomyogenesis to Mechanotransduction

Mechanosensitive molecular mechanisms of myocardial fibrosis in living myocardial slices

Mechano-regulated cell–cell signaling in the context of cardiovascular tissue engineering

Mechanical stimulation of induced pluripotent stem derived cardiac fibroblasts

Recent Advances in Quantifying the Mechanobiology of Cardiac Development Via Computational Modeling

Traction Force Microscopy of Engineered Cardiac Tissues

Force-sensing protein expression in response to cardiovascular mechanotransduction

View from the heart: cardiac fibroblasts in development, scarring and regeneration

Distinct cytoskeletal regulators of mechanical memory in cardiac fibroblasts and cardiomyocytes

Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies

Fibrotic extracellular matrix impacts cardiomyocyte phenotype and function in an iPSC-derived isogenic model of cardiac fibrosis

The LINC Between Mechanical Forces and Chromatin

A positive mechanobiological feedback loop controls bistable switching of cardiac fibroblast phenotype